Ezeb v. Sandoz Pharmaceuticals

Supreme Court of Louisiana

Ezeb v. Sandoz Pharmaceuticals

192 So. 3d 756, 2016 La. LEXIS 1420, 2016 WL 3513429

Supreme Court of Louisiana·Decided June 3, 2016·No. No. 2016-CC-0886·Published

Opinion

In re Novartis Pharmaceuticals Corporation, successor by merger to Sandoz Pharmaceuticals Corporation; — Defendant; Applying For Writ of Certiorari and/or Review, Parish of Orleans, Civil District Court Div. A, No. 92-20622; to the Court of Appeal, Fourth Circuit, No. 2016-C-0428.

Granted. Under the unique facts presented, the district court did not abuse its great discretion in granting relator’s motion. Accordingly, the judgment of the court of appeal is reversed, and the judgment of the district court is reinstated.

JOHNSON, C.J., KNOLL and CLARK, JJ., would deny.

Free access — add to your briefcase to read the full text and ask questions with AI

In re Novartis Pharmaceuticals Corporation, successor by merger to Sandoz Pharmaceuticals Corporation; — Defendant; Applying For Writ of Certiorari and/or Review, Parish of Orleans, Civil District Court Div. A, No. 92-20622; to the Court of Appeal, Fourth Circuit, No. 2016-C-0428.

Granted. Under the unique facts presented, the district court did not abuse its great discretion in granting relator’s motion. Accordingly, the judgment of the court of appeal is reversed, and the judgment of the district court is reinstated.

JOHNSON, C.J., KNOLL and CLARK, JJ., would deny.

Ezeb v. Sandoz Pharmaceuticals, 192 So. 3d 756, 2016 La. LEXIS 1420, 2016 WL 3513429 (La. 2016).

Pincite

192 So. 3d 756 (Ezeb v. Sandoz Pharmaceuticals) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.